CD34 and graft versus host disease: However, the benefit (the absence of GVHD) from this CD34 selected haplotype transplant approach is offset by a very slow immune recovery due to the small number of T cells infused and the ATG application, which result in high rates of opportunistic infections, such as viral and fungal infections, leading to a high TRM.